By default I already include Oncovir or IL-7 into the possible merger. Have you noticed that NWBO consistently provided research grant to Dr. Vivek Subbiah over the past many years? But have we seen any publications related to Direct other than the one about the Direct trial? What kind of research has NWBO been funding? Keep in mind all these technologies are complementary which means they are fungible.